Economy

Zimmer Biomet Holdings, Inc. (ZBH)

Zimmer Biomet Holdings, Inc. (ZBH)”

Auxier Asset Management boosted its stake in Zimmer Biomet Holdings by 3.3% in the fourth quarter. (NYSE:ZBH) by 35.7% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. GLG LLC now owns 10,058 shares of the medical equipment provider's stock valued at $1,038,000 after buying an additional 639 shares during the period. The "percentage off the 52-week high or low" refers to when a stock current price is relative to where it has traded over the last 52 weeks. Insiders sold a total of 111,262 shares of company stock worth $13,103,927 in the last three months.

Nuveen Asset Management LLC decreased its position in shares of Zimmer Biomet Holdings, Inc.

Shares of the company are trading at $129.47 which is marginally higher than the 50 day moving average of $127.00 and which is marginally over the 200 day moving average of $120.27.

Zimmer Biomet Holdings, Inc. IHT Wealth Management LLC raised its stake in Zimmer Biomet Holdings by 28.4% in the first quarter. Closely-held shares are those owned by insiders, major shareholders and employees, while restricted stock refers to insider shares that can not be traded because of a temporary restriction such as the lock-up period after an initial public offering.

First PREMIER Bank lowered its position in shares of Zimmer Biomet Holdings, Inc. Sandy Spring Bank raised its position in shares of Zimmer Biomet Holdings by 1.7% in the first quarter.

With these kinds of figures it is worthy to note that Zimmer Biomet Holdings, Inc. Guggenheim raised shares of Zimmer Biomet Holdings from a neutral rating to a buy rating and set a $157.00 price objective for the company in a research note on Wednesday, July 12th. The original version of this news story can be read at https://sportsperspectives.com/2017/07/20/zimmer-biomet-holdings-inc-zbh-stake-reduced-by-jarislowsky-fraser-ltd-updated-updated-updated-updated.html. Nicholas Co. Inc. WI now owns 332,705 shares of the medical equipment provider's stock worth $34,335,000 after buying an additional 34,610 shares during the period. Oppenheimer Holdings, Inc. set a $132.00 target price on shares of Zimmer Biomet Holdings and gave the stock a "buy" rating in a research report on Friday, April 28th. The company has a market cap of $26.45 billion, a PE ratio of 53.70 and a beta of 1.21. Parkside Financial Bank & Trust now owns 839 shares of the medical equipment provider's stock worth $102,000 after buying an additional 22 shares during the last quarter. Levin Capital Strategies L.P. increased its stake in Zimmer Biomet Holdings by 41.9% in the fourth quarter.

Zimmer Biomet Holdings (NYSE:ZBH) last posted its earnings results on Thursday, April 27th.

More news: Livforsakringsbolaget Skandia Omsesidigt Maintains Position in Smith (AO) Corporation (NYSE:AOS)

According to the Recommendation Trends of the stock polled by Finviz, the company has a consensus recommendation of 2.1 out of the scale from 1 to 5 where 1 stands for Buy and 5 means Sell. In the last earnings report the EPS was $2.44 and is estimated to be $8.51 for the current year with 201,644,000 shares outstanding. During the same period previous year, the business posted $2.00 earnings per share. The firm's revenue for the quarter was up 3.8% on a year-over-year basis.

Investors of this company earned a return of 0.80% on the assets it owns in past twelve month. The ex-dividend date is Wednesday, June 21st. This dividend amount will represent a yeild of $0.73. Zimmer Biomet Holdings's dividend payout ratio is presently 39.67%.

A number of other equities analysts have also commented on ZBH. If you are accessing this report on another website, it was copied illegally and reposted in violation of US and worldwide copyright & trademark legislation. For investors, a positive change in price indicates an upward buying pressure or positive momentum while a negative change in price designates a downward momentum for that stock. Wells Fargo & Company cut shares of Zimmer Biomet Holdings from an "outperform" rating to a "market perform" rating in a research note on Friday, April 28th. Canaccord Genuity reissued a "buy" rating on shares of Zimmer Biomet Holdings in a report on Friday, April 28th. The shares were sold at an average price of $124.56, for a total value of $2,208,573.36. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.

In related news, VP Chad F. Phipps sold 6,200 shares of the firm's stock in a transaction on Friday, May 5th. Also, insider Sang Yi sold 17,731 shares of the firm's stock in a transaction on Monday, June 12th.

As of the end of the quarter Bb&t Corp had bought a total of 75 shares growing its stake by 2.0%. The disclosure for this sale can be found here. Outstanding shares denotes a company's stock now held by all its shareholders, comprising share blocks apprehended by institutional investors and limited shares owned by the officers and insiders of the organization.

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.



Like this

loading...
loading...

Latest


22 July 2017
D-backs open with back-to-back-to-back HRs
First pitch is scheduled for 5:10 p.m., with pregame coverage beginning 40 minutes earlier on 98.7 FM, Arizona's Sports Station. Despite playing without their newest asset, the Diamondbacks proved they are one of the most unsafe teams in baseball.

22 July 2017
Tree Falls on Former Doordarshan Anchor; Husband Blames BMC
Mrs Nath was pinned down by the weight of the tree, suffering catastrophic internal injuries and fractures. A coconut tree turned deadly for a woman in Mumbai as it took her life.

22 July 2017
Gadkari lays foundation stone for 2nd Brahmani bridge in Odisha
Gadkari said 111 rivers across the country would be brought into a water route that would facilitate cheaper transport of goods. This would enable it handle a variety of vessels and cargo.

22 July 2017
SLM Corporation (NASDAQ:SLM) Releases FY17 Earnings Guidance
Its Private Education Loans that it owns or services are originated and funded by its subsidiary, Sallie Mae Bank (the Bank). In other news, EVP Laurent Charles Lutz sold 170,000 shares of the company's stock in a transaction dated Monday, April 24th.

22 July 2017
Marc Kasowitz out as Trump's lead Russiagate attorney
Trump's personal attorney, CBS News chief White House correspondent Major Garrett reports. According to a member of Kasowitz's legal team, the firm was originally tasked.

22 July 2017
Ramon Torres starting as Royals face White Sox
That's five straight starts for Lopez in which he has allowed two or fewer runs while pitching six or more innings. Jorge Bonifacio walked to load the bases with no outs prior to Merrifield's fly ball to center field.

22 July 2017
MA Cuts Position in Kohl's Corporation (NYSE:KSS)
The Target Price for Kohl's Corp (NYSE:KSS) is $40.55/share according to the consensus analysis of analysts working on the stock. Finally, Berkshire Asset Management LLC PA raised its position in shares of Kohl's Corporation by 12.0% in the first quarter.

22 July 2017
Regulus Therapeutics Inc. (RGLS) closed at $0.88 in the last trading session
Analysts are expecting EPS growth rates to be at -42.90% this quarter and EPS estimate for next year reflect 22.40% growth rate. Regulus Therapeutics (NASDAQ:RGLS) now has a trailing P/E of -0.58 while its forward P/E according to Thomson Reuters is -0.85.

22 July 2017
The BidaskClub Downgrades PNM Resources, Inc. (Holding Co.) (PNM) to Sell
On Friday, May 19 the insider McMorran James D sold $431,590. (Holding Co.) with MarketBeat.com's FREE daily email newsletter . The firm has "Buy" rating by Williams Capital Group given on Tuesday, October 4. (Holding Co.) by 3.9% in the first quarter.

22 July 2017
Writer receives threat letter asking him to convert to Islam
Ramanunni said he had ignored the letter initially, but other senior writers advised him to file a police complaint. The letter allegedly asked him to convert in six months or warned that he would be killed on failing to do so.